Late relapse of metastatic testicular nonseminomatous germ cell cancer: Surgery is needed for cure

BJU International

Volumn 98, Issue 2, 2006, Pages 353-358

  Geldart, Thomas R ^a   Gale, Joanna ^b   McKendrick, Joe ^c   Kirby, Julie ^a   Mead, Graham ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b PORTSMOUTH HOSPITALS NHS TRUST   (United Kingdom)

^c BOX HILL HOSPITAL   (Australia)

Author keywords

Late relapse; Metastatic nonseminomatous germ cell cancer; Surgery

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; GERM CELL TUMOR; HUMAN; MALE; METASTASIS; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; TESTIS TUMOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; GERMINOMA; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 33745726529     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06250.x     Document Type: Article

References (26)

1. Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA, Loehrer PJ. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987; 316: 1435-40
2. Broun ER, Nichols CR, Kneebone P et al. Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 1992; 117: 124-8
3. Loehrer PJ Sr, Gonin R, Nichols CR, Weathers T, Einhorn LH. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 1998; 16: 2500-4
4. Schmoll HJ, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377-99
5. Pico JL, Rosti G, Kramar A et al. A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol 2005; 16: 1152-9
6. Motzer RJ, Sheinfeld J, Mazumdar M et al. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. J Clin Oncol 2000; 18: 2413-8
7. Mead GM, Cullen MH, Huddart R et al. A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial. Br J Cancer 2005; 93: 178-84
8. Baniel J, Foster RS, Gonin R, Messemer JE, Donohue JP, Einhorn LH. Late relapse of testicular cancer. J Clin Oncol 1995; 13: 1170-6
9. George DW, Foster RS, Hromas RA et al. Update on late relapse of germ cell tumor: a clinical and molecular analysis. J Clin Oncol 2003; 21: 113-22
10. Gerl A, Clemm C, Schmeller N, Hentrich M, Lamerz R, Wilmanns W. Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol 1997; 8: 41-7
11. Michael H, Lucia J, Foster RS, Ulbright TM. The pathology of late recurrence of testicular germ cell tumors. Am J Surg Pathol 2000; 24: 257-73
12. Anonymous. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15: 594-603
13. Peckham MJ, Barrett A, Liew KH et al. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cisplatin (BEP). Br J Cancer 1983; 47: 613-9
14. Einhorn LH, Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1977; 87: 293-8
15. Lewis CR, Fossa SD, Mead G et al. BOP/VIP - a new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours. Ann Oncol 1991; 2: 203-11
16. Geldart TR, Simmonds PD, Mead GM. Orchidectomy after chemotherapy for patients with metastatic testicular germ cell cancer. BJU Int 2002; 90: 451-5
17. Shahidi M, Norman AR, Dearnaley DP, Nicholls J, Horwich A, Huddart RA. Late recurrence in 1263 men with testicular germ cell tumors. Multivariate analysis of risk factors and implications for management. Cancer 2002; 95: 520-30
18. Kuczyk MA, Bokemeyer C, Kollmannsberger C et al. Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experience. World J Urol 2004; 22: 55-9
19. Dieckmann KP, Albers P, Classen J et al. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases. J Urol 2005; 173: 824-9
20. Kirk D. Workshop on surgery for metastatic disease. In Jones WG, Appleyard I, Harnden P, Joffe JK eds, Germ Cell Tumours IV. London: John Libbey & Co. Ltd., 1998: 281-5
21. Mead GM, Stenning SP, Parkinson MC et al. The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party. J Clin Oncol 1992; 10: 85-94
22. Ulbright TM, Loehrer PJ, Roth LM, Einhorn LH, Williams SD, Clark SA. The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases. Cancer 1984; 54: 1824-33
23. Carl J, Christensen TB, von der Maase H. Cisplatinum dose dependent response in germ cell cancer evaluated by tumour marker modelling. Acta Oncol 1992; 31: 749-53
24. DeLeo MJ, Greco FA, Hainsworth JD, Johnson DH. Late recurrences in long-term survivors of germ cell neoplasms. Cancer 1988; 62: 985-8
25. Terebelo HR, Taylor HG, Brown A et al. Late relapse of testicular cancer. J Clin Oncol 1983; 1: 566-71
26. Ronnen EA, Kondagunta GV, Bacik J et al. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy. J Clin Oncol 2005; 23: 6999-7004